19th Annual SBUR Meeting: Molecular Targets for Diagnostic and Therapeutics in Ur
19th Annual SBUR Meeting: Molecular Targets for Diagnostic and Therapeutics in Ur
批准号:
7798735
负责人:
Vinata B Lokeshwar
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2010-10-31
关键词:
AddressAwardBenignBladder DiseasesClinicalCollaborationsCongressesDataDiagnosticEuropeanFacultyFertilizationFundingGenitourinary systemGoalsGrantHealthJointsKidneyKnowledgeLearningLouisianaMalignant - descriptorMolecularMolecular TargetOccupationsPatientsPostdoctoral FellowPrognostic MarkerProstateResearchResearch PersonnelScientistSocietiesTechnologyTherapeuticTranslational ResearchTranslationsTravelUrologic DiseasesUrologycellular targetingexperiencefallsgraduate studentmeetingsmembernovelnovel diagnosticsnovel markerpeerplanetary Atmospherepostersprofessorsuccesssymposiumurologic
中文摘要
申请者描述(由申请人提供):本申请旨在为参加第8届世界基础泌尿外科研究大会的见习研究员(研究生、住院医生、临床和博士后研究员以及助理教授以下的教员)提供25项旅费奖励,每人1000美元。这是基础泌尿研究会(SBUR)和欧洲泌尿研究会(ESUR)的联席会议,也是第19届秋季SBUR年会。世界大会将于2009年11月5日至8日在路易斯安那州新奥尔良举行。SBUR是一个由科学家组成的学会,专门从事良性和恶性泌尿系统疾病的研究。协会已连续18年举办独立的秋季年会,取得了巨大成功。在每次会议上及时讨论年度主题,特别强调泌尿外科和另一个相关研究领域的交叉受精。2009年会议将重点讨论“泌尿外科诊断和治疗的分子目标”这一主题。会议的目标是加快将新的诊断和预后标记物和治疗方法转化到患者床边,识别和开发新的分子和细胞靶标,并了解新的实验战略、概念和尖端技术。在膀胱、前列腺和肾脏的良性和恶性疾病方面的关键进展将通过临床和翻译研究中对话的小型研讨会来强调。受训人员将有机会在两个协会的同行和高级成员之间建立联系,在招贴会上介绍他们的数据,并在某些情况下作为讲台发言。会议的特邀演讲者是各自领域的领导者,他们提供了丰富的知识和经验。会议的气氛友好而非正式,为学员提供了参与和建立合作的独特机会和鼓励。为了实现这种互动,这些受训人员需要为他们的旅费提供支持。如果得到资助,这笔赠款将对本次会议的教育目标做出重大贡献。
第八届世界泌尿外科研究大会(第19届秋季基础学会)的目标
尿路研究会议)的目的是加强基础和临床科学家在我们的泌尿系统疾病和泌尿生殖系统健康研究方面的持续对话。我们的目标是通过识别和利用新的分子和细胞靶点,以及通过了解新的实验策略、概念和尖端技术,加快新标记物和治疗方法在患者床边的转化。本次会议的其他特色包括招聘会和卫星“助学金-如何操作”,与会者和授权机构的专家之间的互动论坛。
英文摘要
DESCRIPTION (provided by applicant): This application seeks funds to provide 25 travel awards of $1000 each to trainee investigators (graduate students, residents, clinical and postdoctoral fellows and faculty below the rank of Assistant Professor) to participate in the 8th World Basic Urological Research Congress. This is a joint meeting between the Society for Basic Urologic Research (SBUR) and the European Society for Urological Research (ESUR) and is also the 19th Annual Fall SBUR Meeting. The World Congress will be held between November 5th and 8th, 2009, in New Orleans, Louisiana. SBUR is a society of scientists specializing in research on benign and malignant urologic diseases. The Society has held its independent Fall Annual Symposia for 18 consecutive years with great success. Timely subject of the year is addressed at each meeting with special emphasis on a cross-fertilization of urology and another relevant field of research. The 2009 meeting will focus on the theme "Molecular Targets for Diagnostics and Therapeutics in Urology". The meeting's objectives are to accelerate the translation of new diagnostic and prognostic markers and treatments to the patient bedside, identify and exploit novel molecular and cellular targets, and learn about new experimental strategies, concepts and cutting-edge technologies. Key advancements in benign and malignant diseases of the bladder, prostate, and kidneys will be emphasized through a mini-symposium on dialogues in clinical and translational research. The trainees will have opportunities to network among peers and senior members of both Societies, to present their data at poster sessions and, in selected cases, as podium presentations. Invited speakers at the meeting are leaders in their respective fields, offering extensive knowledge and experience. The atmosphere of the meetings is friendly and informal, providing encouragement and unique opportunities for trainees to participate and establish collaborations. In order for such interactions to occur, these trainees need support for their travel expenses. If funded, this grant will contribute significantly to the educational objectives of this meeting.
The objective of this 8th World Urological Research Congress (19th Fall Society for Basic
Urologic Research Meeting) is to strengthen the ongoing dialogue between basic and clinical scientists in our study of urologic disease and genitourinary tract health. Our goals are to accelerate the translation of new markers and treatments to the patient bedside, by identifying and exploiting novel molecular and cellular targets, and by learning about new experimental strategies, concepts and cutting-edge technologies. Additional features of this meeting include, a job fair and a satellite "Grants - How to" interactive forum between meeting attendees and experts from granting agencies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarker guided combinations for treating high-risk bladder cancer
-
批准号:10718874
-
项目类别:
-
资助金额:$55.7万
-
财政年份:2023
-
负责人:Vinata B Lokeshwar
-
依托单位:
Novel Biomarkers for the Clinical Management of Bladder Cancer
-
批准号:10198863
-
项目类别:
-
资助金额:$1.57万
-
财政年份:2018
-
负责人:Vinata B Lokeshwar
-
依托单位:
Novel Biomarkers for the Clinical Management of Bladder Cancer
-
批准号:10461807
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2018
-
负责人:Vinata B Lokeshwar
-
依托单位:
Novel Biomarkers for the Clinical Management of Bladder Cancer
-
批准号:10659210
-
项目类别:
-
资助金额:$42.98万
-
财政年份:2018
-
负责人:Vinata B Lokeshwar
-
依托单位:
Role of CYP3A4 in Prostate Cancer
-
批准号:8676313
-
项目类别:
-
资助金额:$16.69万
-
财政年份:2014
-
负责人:Vinata B Lokeshwar
-
依托单位:
Role of CYP3A4 in Prostate Cancer
-
批准号:8803773
-
项目类别:
-
资助金额:$2.04万
-
财政年份:2014
-
负责人:Vinata B Lokeshwar
-
依托单位:
Role of CYP3A4 in Prostate Cancer
-
批准号:9169812
-
项目类别:
-
资助金额:$17.99万
-
财政年份:2014
-
负责人:Vinata B Lokeshwar
-
依托单位:
Dietary Combination For Prevention of Metastatic Renal Cell Carcinoma
-
批准号:8776933
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2013
-
负责人:Vinata B Lokeshwar
-
依托单位:
Dietary Combination For Prevention of Metastatic Renal Cell Carcinoma
-
批准号:8633231
-
项目类别:
-
资助金额:$32.9万
-
财政年份:2013
-
负责人:Vinata B Lokeshwar
-
依托单位:
Glycosaminoglycan-based inhibitors for treatment of prostate cancer
-
批准号:7265404
-
项目类别:
-
资助金额:$26.05万
-
财政年份:2007
-
负责人:Vinata B Lokeshwar
-
依托单位:
Glycosaminoglycan-based inhibitors for treatment of prostate cancer
-
批准号:7385091
-
项目类别:
-
资助金额:$26.06万
-
财政年份:2007
-
负责人:Vinata B Lokeshwar
-
依托单位:
Glycosaminoglycan-based inhibitors for treatment of prostate cancer
-
批准号:7767001
-
项目类别:
-
资助金额:$26.06万
-
财政年份:2007
-
负责人:Vinata B Lokeshwar
-
依托单位:
Glycosaminoglycan-based inhibitors for treatment of prostate cancer
-
批准号:7570665
-
项目类别:
-
资助金额:$26.06万
-
财政年份:2007
-
负责人:Vinata B Lokeshwar
-
依托单位:
Glycosaminoglycans For IC Pathophysiology and Prognosis
-
批准号:6799332
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2003
-
负责人:Vinata B Lokeshwar
-
依托单位:
Glycosaminoglycans For IC Pathophysiology and Prognosis
-
批准号:6940744
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2003
-
负责人:Vinata B Lokeshwar
-
依托单位:
Glycosaminoglycans For IC Pathophysiology and Prognosis
-
批准号:6711538
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2003
-
负责人:Vinata B Lokeshwar
-
依托单位:
Mechanisms of Bladder Cancer Progression
-
批准号:7069498
-
项目类别:
-
资助金额:$26.22万
-
财政年份:1997
-
负责人:Vinata B Lokeshwar
-
依托单位:
MECHANISIMS OF BLADDER CANCER PROGRESSION
-
批准号:6137588
-
项目类别:
-
资助金额:$10.71万
-
财政年份:1997
-
负责人:Vinata B Lokeshwar
-
依托单位:
Mechanisms of Bladder Cancer Progression
-
批准号:6895254
-
项目类别:
-
资助金额:$26.85万
-
财政年份:1997
-
负责人:Vinata B Lokeshwar
-
依托单位:
Mechanisms of Bladder Cancer Progression
-
批准号:6615853
-
项目类别:
-
资助金额:$28.69万
-
财政年份:1997
-
负责人:Vinata B Lokeshwar
-
依托单位:
海外基金